Last December, a company by the name of Juno Therapeutics (NASDAQ: JUNO) raised $304 million in its market debut. Does this biotech have the cure for cancer?
It was originally speculated that the Fed would raise rates in the June meeting, but that expectation went away quickly over the last several months with less-than-stellar economic growth.
The beauty of Sonos is that users have complete flexibility in how they set up and control their home audio. Here's why we're clamoring for a Sonos IPO.
There's a very good reason most mutual fund managers can't beat the S&P 500. And it's the very reason you can get market-beating returns year in and year out...
The REAL secret to consistent, reliable stock market profits is simple: own top quality dividend stocks! We'll show you how to get consistent and reliable income from dividend stocks.
Send My FREE Report Now
Sign up to receive your free report. After signing up, you'll begin receiving the Wealth Daily e-letter daily.